Evaluation of five different methods for diagnosis of Helicobacter pylori from fecal samples
- PMID: 39449634
- DOI: 10.1111/apm.13483
Evaluation of five different methods for diagnosis of Helicobacter pylori from fecal samples
Abstract
Accurate detection of Helicobacter pylori and its antimicrobial resistance is essential for eradication of the infections. The aim of this study was to compare five different CE-IVD marked assays in detection of H. pylori from 268 clinical stool samples. Samples were considered positive for H. pylori when at least three of the five tests were positive. Amplified IDEIA Hp StAR (Oxoid) and Premier Platinum HpSA PLUS (Meridian Bioscience Inc.) assays showed sensitivity of 100% [95% CI (confidence interval): 87-100] and LIAISON® Meridian H. pylori SA (DiaSorin) of 83.3% (95% CI: 66-93). Specificities of the assays were 94.5% (95% CI: 91-97), 95.4%; (95% CI: 92-97), and 97.1% (95% CI: 94-99) respectively. Amplidiag® H. pylori + ClariR (Mobidiag) assay showed 93.3% (95% CI: 78-99) and Allplex™ H. pylori & ClariR Assay (Seegene Inc.) 36.7% (95% CI: 22-55) sensitivity, while specificity of both was 97.9% (95% CI: 95-99). The Amplidiag® and Allplex™ assays concordantly detected clarithromycin resistance in positive for H. pylori samples. The Amplidiag® assay showed the highest accuracy, namely 97.4% (95% CI: 95-99). These data provide helpful information for planning laboratory diagnostics of H. pylori and detection of clarithromycin resistance from stool samples.
Keywords: Helicobacter pylori; antigen test; clarithromycin; molecular diagnostics; stool sample.
© 2024 Scandinavian Societies for Pathology, Medical Microbiology and Immunology.
Similar articles
-
Comparison of three different molecular biology assays (AllPlexTMH. pylori & ClariR assay, Amplidiag® H. pylori + ClariR and RIDA®GENE Helicobacter pylori) to detect Helicobacter pylori and clarithromycin resistance in stool samples.Diagn Microbiol Infect Dis. 2025 Jun;112(2):116771. doi: 10.1016/j.diagmicrobio.2025.116771. Epub 2025 Feb 25. Diagn Microbiol Infect Dis. 2025. PMID: 40043336
-
Molecular diagnosis of Helicobacter pylori infection in gastric biopsies: Evaluation of the Amplidiag® H. pylori + ClariR assay.Helicobacter. 2019 Apr;24(2):e12560. doi: 10.1111/hel.12560. Epub 2018 Dec 12. Helicobacter. 2019. PMID: 30548730
-
Evaluation of the Allplex™ H pylori and ClariR PCR Assay for Helicobacter pylori detection on gastric biopsies.Helicobacter. 2020 Aug;25(4):e12702. doi: 10.1111/hel.12702. Epub 2020 May 19. Helicobacter. 2020. PMID: 32426894
-
Diagnostic Accuracy of a Noninvasive Test for Detection of Helicobacter pylori and Resistance to Clarithromycin in Stool by the Amplidiag H. pylori+ClariR Real-Time PCR Assay.J Clin Microbiol. 2020 Mar 25;58(4):e01787-19. doi: 10.1128/JCM.01787-19. Print 2020 Mar 25. J Clin Microbiol. 2020. PMID: 31996442 Free PMC article.
-
[Helicobacter pylori stool antigen test].Nihon Rinsho. 2004 Mar;62(3):464-9. Nihon Rinsho. 2004. PMID: 15038088 Review. Japanese.
References
REFERENCES
-
- Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311–1315. https://doi.org/10.1016/s0140‐6736(84)91816‐6
-
- Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002;347:1175–1186. https://doi.org/10.1056/NEJMra020542
-
- Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–789. https://doi.org/10.1056/NEJMoa001999
-
- Burucoa C, Axon A. Epidemiology of Helicobacter pylori infection. Helicobacter. 2017;22(Suppl. 1): e12403. https://doi.org/10.1111/hel.12403
-
- Qiu E, Li Z, Han S. Methods for detection of Helicobacter pylori from stool sample: current options and developments. Braz J Microbiol. 2021;52:2057–2062. https://doi.org/10.1007/s42770‐021‐00589‐x
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous